Impossible to answer with complete confidence. It may be the last chance for Floyd to get some extra cash before the S1 because he knows it will be approved shortly after the release of the 10K. I wouldn't want to dilute after a significant increase in share price after those two catalysts are brought to light. I think investors have to be reminded that this is Floyd's company and life work; running a business is not easy and involves substantial risk especially in OTC land.